To be honest I would rather just get another aspire deal done now and then do a real capital raise in 2015 when we are already up 500 percent. Then raising the funds for a Ph3 will be childs play and no big hit to our stock price. Who cares at that point anyway.
Point is dilution will be small now and will remain small until we have a proven drug or 3 so who cares... Kerx raised 90 million at $8.40pps after they proved K worked as well as they could have hoped and the stock kept going up and hit 10. It was hilarious to watch the shorts scream.
Market Data 
Markets 
AI
